CH541560A - Préparation de dérivés de la pyridine trisubstituée - Google Patents

Préparation de dérivés de la pyridine trisubstituée

Info

Publication number
CH541560A
CH541560A CH164872A CH541560DA CH541560A CH 541560 A CH541560 A CH 541560A CH 164872 A CH164872 A CH 164872A CH 541560D A CH541560D A CH 541560DA CH 541560 A CH541560 A CH 541560A
Authority
CH
Switzerland
Prior art keywords
derivatives
preparation
trisubstituted pyridine
trisubstituted
pyridine
Prior art date
Application number
CH164872A
Other languages
English (en)
Inventor
Ernest Barth Wayne
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CH541560A publication Critical patent/CH541560A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH164872A 1971-02-16 1972-02-04 Préparation de dérivés de la pyridine trisubstituée CH541560A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11587871A 1971-02-16 1971-02-16
US25664172A 1972-05-25 1972-05-25

Publications (1)

Publication Number Publication Date
CH541560A true CH541560A (fr) 1973-10-31

Family

ID=26813670

Family Applications (1)

Application Number Title Priority Date Filing Date
CH164872A CH541560A (fr) 1971-02-16 1972-02-04 Préparation de dérivés de la pyridine trisubstituée

Country Status (9)

Country Link
US (2) US3700681A (fr)
AT (1) AT315842B (fr)
BE (1) BE778771A (fr)
CA (1) CA978962A (fr)
CH (1) CH541560A (fr)
DE (2) DE2204195C2 (fr)
FR (1) FR2125309B1 (fr)
GB (2) GB1367669A (fr)
NL (1) NL174349C (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207639A1 (es) * 1973-12-26 1976-10-22 Pfizer Un procedimiento para preparar pirido (3,2-d)1,3-dioxin-6-epoxietanos y compuestos intermediarios desprovistos de actividad terapeutica
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols
US4011231A (en) * 1975-10-03 1977-03-08 Pfizer Inc. 2-Phenyl-6-(1-hydroxy-2-t-butylaminoethyl)-4H-pyrido[3,2-d]-1,3-dioxin maleate and its use as an intermediate
SE7708307L (sv) * 1976-08-26 1978-02-27 Pfizer Forfarande for framstellning av farmaceutiska kompositioner anvendbara sasom bronkodilatorer
US4175128A (en) * 1979-01-03 1979-11-20 Pfizer Inc. Method for treating congestive heart failure
US4632992A (en) * 1981-02-09 1986-12-30 Pfizer Inc. Intermediates for preparing pirbuterol and analogs
SU1194273A3 (ru) * 1981-02-09 1985-11-23 Пфайзер Инк (Фирма) Способ получени пирбутерола или его аналогов
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
EP0220054A3 (fr) * 1985-10-16 1987-12-02 Glaxo Group Limited Dérivés d'éthanolamine
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
AU2270092A (en) * 1991-06-26 1993-01-25 Sepracor, Inc. Methods and compositions for treating pulmonary and cardiac disorders using optically pure (-)pirbuterol
WO1993000090A1 (fr) * 1991-06-26 1993-01-07 Sepracor, Inc. Methodes et compositions pour le traitement des troubles pulmonaires et cardiaques avec du pirbuterol optiquement pur (+)
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
NZ545748A (en) * 2003-08-29 2010-03-26 Ranbaxy Lab Ltd Isoxazoline derivatives as inhibitors of phosphodiesterase type-IV
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
WO2005092860A1 (fr) * 2004-03-23 2005-10-06 Pfizer Limited Composes servant au traitement de maladies
EP1934219A1 (fr) 2005-09-16 2008-06-25 Ranbaxy Laboratories Limited Pyrazolo[3,4-b]pyridines substituees en tant qu'inhibiteurs de la phosphodiesterase
BRPI0617674A2 (pt) 2005-10-19 2011-08-02 Ranbaxy Lab Ltd composições farmacêuticas e seus usos
WO2007045980A1 (fr) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de la phosphodiesterase de type iv
CL2007002427A1 (es) * 2006-08-22 2008-03-14 Ranbaxy Lab Ltd Compuestos derivados heterociclicos, inhibidores de metaloproteinasa de matriz; proceso de preparacion; composicion farmaceutica, util para el tratamiento o profilaxis de enfermedades inflamatorias o desordenes autoinmunes.
WO2008035316A2 (fr) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibiteurs de phosphodiestérase
CN101616901A (zh) * 2006-09-22 2009-12-30 兰贝克赛实验室有限公司 Iv型磷酸二酯酶的抑制剂
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
CN101801376A (zh) * 2007-03-14 2010-08-11 兰贝克赛实验室有限公司 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物
WO2008111009A1 (fr) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Dérivés de pyrazolo[3,4-b]pyridine comme inhibiteurs de phosphodiestérases
EP2111861A1 (fr) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de type IV de la phosphodiestérase
CA2807097A1 (fr) 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Inhibiteurs de metalloproteinase de matrice
KR20130140688A (ko) 2010-09-24 2013-12-24 랜박시 래보러터리스 리미티드 기질 메탈로프로테나제 저해제
CN103848781B (zh) * 2012-11-30 2017-06-30 重庆华邦制药有限公司 高选择性氧化二羟甲基吡啶中一个羟甲基的方法
PE20151158A1 (es) 2012-12-03 2015-08-14 Pfizer Moduladores selectivos del receptor de androgenos novedosos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1089189A (en) * 1964-09-23 1967-11-01 Koninklijke Pharma Fab Nv Ethers of -(2-pyridyl)benzyl alcohols

Also Published As

Publication number Publication date
CA978962A (en) 1975-12-02
GB1367668A (en) 1974-09-18
DE2265581C2 (de) 1982-07-01
NL7201471A (fr) 1972-08-18
DE2204195A1 (de) 1972-08-17
NL174349C (nl) 1984-06-01
US3763173A (en) 1973-10-02
FR2125309B1 (fr) 1976-05-14
GB1367669A (en) 1974-09-18
DE2204195C2 (de) 1981-11-19
BE778771A (fr) 1972-08-01
AT315842B (de) 1974-06-10
FR2125309A1 (fr) 1972-09-29
NL174349B (nl) 1984-01-02
US3700681A (en) 1972-10-24

Similar Documents

Publication Publication Date Title
CH541560A (fr) Préparation de dérivés de la pyridine trisubstituée
BE781428A (fr) Derives de la pyridine
CH539643A (fr) Procédé pour la préparation de dérivés de la benzazine
CH512461A (fr) Préparation de composés caroténoïdes
CH532034A (fr) Procédé de préparation de dibenzo-oxépine-spiro-dioxolannes substiués
SE417969B (sv) Forfarande for framstellning av 3-metylencefalosporinforeningar
CH535226A (fr) Procédé de préparation de bis-chromones
OA04182A (fr) Procédé de préparation de 3-hydroxyméthyl-isoquinoléines substituées et dérivés.
RO71183A (fr) Procede de preparation des 20-one-steroides substitues
CH532056A (fr) Procédé de préparation de dérivés de 4-amino-2-styrylquinazoline
CH522577A (fr) Procédé de préparation de 5-cyclohexadécène-1-one
CH540922A (fr) Procédé de préparation de 2-phényl-3-aminoacyl-benzo-thiazolines
SE417318B (sv) Forfarande for framstellning av oxofurylesterderivat av penicillin
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
CH533618A (fr) Procédé de préparation de dérivés de nitroso-1-pyrrolidine
BE790727A (fr) Preparation de pyrrolidinone-2
CH545282A (de) Procédé de préparation de dérivés basiques de la cystéine
BE793175A (fr) Preparation de 3-alkylthiomethylcephalosporines
BE807842Q (fr) Preparation de derives de quinoxaline-2-carboxamides
BE786328A (fr) Preparation de polyurethannes
CH543476A (fr) Procédé de préparation de dérivés gem.-diaryléthyléniques
CH540286A (fr) Procédé de préparation de dérivés de la thiazolinopyrimidinone-5
SE382051B (sv) Forfarande for framstellning av 3-sulfonamid-4-hydroxifenyl-2-piperidylkarbinoler
MC939A1 (fr) Procédé de préparation de dérivés de benzamide
CH540924A (fr) Procédé de préparation de phénothiazinones substituées

Legal Events

Date Code Title Description
PL Patent ceased